News | March 13, 2021
AstraZeneca Pharma India receives approval for supplying Osimertinib in India
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Vivimed strategy is to increase its share of Branded products in CIS Markets.
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
Bharat Biotech expects to share further details of the trial results as additional data become available.
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Subscribe To Our Newsletter & Stay Updated
